Corpus Intelligence IC Memo — WOODLAND HEIGHTS MED CENTER 2026-04-26 14:13 UTC
IC Memo — WOODLAND HEIGHTS MED CENTER
Investment Committee Memorandum | TX | 145 beds | Grade C | EBITDA uplift $9.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WOODLAND HEIGHTS MED CENTER

CCN 450484 | ANGELINA, TX | 145 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WOODLAND HEIGHTS MED CENTER is a 145-bed suburban community hospital in ANGELINA, TX with $127.0M in net patient revenue and a 13.3% operating margin. The hospital serves a payer mix of 31.0% Medicare, 4.4% Medicaid, and 64.6% commercial.

Thesis: Turnaround. Our ML models identify $9.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.3% to 20.6% (+736bps).

Net Revenue HCRIS$127.0M
Current EBITDA COMPUTED$16.9M
Operating Margin COMPUTED13.3%
Occupancy HCRIS52.0%
Revenue / Bed COMPUTED$876K
Net-to-Gross HCRIS10.5%
Distress Probability ML46.4%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
165
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 13.3% places it above the state median. Among 165 size-comparable peers (72-290 beds), the median margin is 2.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (72-290), prioritizing same-state peers. 165 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WOODLAND HEIGHTS MED CENTER (Target)TX145$127.0M13.3%
DELL CHILDRENS MEDICAL CENTERTX262$901.9M25.5%
DRISCOLL CHILDRENS HOSPITALTX215$694.3M29.4%
ROUND ROCK HOSPITALTX165$681.4M8.7%
METHODIST WEST HOUSTON HOSPITATX270$529.7M15.5%
HILLCREST BAPTIST MEDICAL CENTTX236$464.8M-6.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
METHODIST RICHARDSON MEDICAL CTX247$449.2M14.6%
DELL SETON MEDICAL CENTER AT TTX225$438.6M-4.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.7M+210bp18mo
Cost to Collect4.5%2.5%$2.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$81K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.7M
Cost to Collect
$2.5M
Denial Rate Reduction
$2.5M
A/R Days Reduction
$1.5M
Clean Claim Rate
$81K
Total EBITDA Uplift$9.3M
Current EBITDA$16.9M
+ RCM Uplift+$9.3M
Pro Forma EBITDA$26.2M
Current Margin13.3%
Pro Forma Margin20.6%
WC Released (1x)$4.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$25.9M$204.6M7.89x51.2%
Base (11x exit)10.0x11.0x$25.9M$233.5M9.01x55.2%
Bull Case9.0x11.0x$23.3M$272.8M11.69x63.5%
Bull (12x exit)9.0x12.0x$23.3M$304.5M13.05x67.2%
Bear Case11.0x10.0x$28.5M$149.5M5.24x39.3%
Bear (11x exit)11.0x11.0x$28.5M$173.7M6.09x43.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 165 hospitals with 72-290 beds
  • Same-state prioritization (n=166)
  • Comp margins: P25=-8.5% / P50=2.4% / P75=13.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.